308. 進行性白質脳症 Disease details / Clinical trials / Drug dev / DR info /

臨床試験数 : 4 / 薬物数 : 4 - (DrugBank : 1) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 2

薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
Fosigotifator
   Calico Life Sciences LLC
      2023   Phase 1/Phase 2   NCT05757141   Canada;Netherlands;United States
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2025   -   NCT07300397   Canada
      2024   Early Phase 1   NCT07272525   Canada
Hematopoetic stem cell transplantation
   University of Pittsburgh
      2012   -   NCT03333200   United States
Palliative care
   University of Pittsburgh
      2012   -   NCT03333200   United States